HeiQ: acquisition of Belgian industrial biotech company

HeiQ: acquisition of Belgian industrial biotech company

The supplier of finishing technology, HeiQ Materials AG, Zurich/Switzerland, has acquired 51% of the share capital and voting rights of Chrisal NV, Lommel/Belgium. The company, with its office and manufacturing site in Lommel, will be renamed HeiQ Chrisal.
Chrisal is a biotechnology company and a leader in innovative ingredients and consumer products that incorporate the benefits of probiotics and symbiotics. It has 3 technology platforms, all with the purpose to create healthy and sustainable microbial ecosystems. The application of its proprietary technology includes cosmetics, personal care, textiles, wound dressings, water purification, air treatment and cleaning products.
With this strategic acquisition HeiQ enters the broader market of surface management and accesses a bio-based green complementary technology platform to its antimicrobials. It gives the company access to the technology platform of prebiotics, probiotics and postbiotics for bio-based odor and stain control for carpets and footwear, anti-allergen effect in mattress and bedding, microbial and viral protection for surfaces, anti-inflammatory effect in wound dressings, probiotic skin enhancing cosmetics, algae and biofilm control in drinking water as well as advanced symbiotic surface protection.

Source:
dfv media group
More information: HeiQ acquisition Chrisal